Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN111931 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Integrin alpha 2 (ITGA2) antibody
- Antibody type
- Monoclonal
- Description
- Affinity chromatography.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- A-1-43
- Vial size
- 0.1 mg
- Storage
- 4°C
Submitted references Emergence of alpha 5 beta 1 fibronectin- and alpha v beta 3 vitronectin-receptor expression in melanocytic tumour progression.
Identification of a melanoma progression antigen as integrin VLA-2.
Antigen dynamics in melanocytic and nevocytic melanoma oncogenesis: anti-ganglioside and anti-ras p21 antibodies as markers of tumor progression.
Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes.
Phenotypic dynamics of tumor progression in human malignant melanoma.
Danen EH, Ten Berge PJ, Van Muijen GN, Van 't Hof-Grootenboer AE, Bröcker EB, Ruiter DJ
Histopathology 1994 Mar;24(3):249-56
Histopathology 1994 Mar;24(3):249-56
Identification of a melanoma progression antigen as integrin VLA-2.
Klein CE, Steinmayer T, Kaufmann D, Weber L, Bröcker EB
The Journal of investigative dermatology 1991 Feb;96(2):281-4
The Journal of investigative dermatology 1991 Feb;96(2):281-4
Antigen dynamics in melanocytic and nevocytic melanoma oncogenesis: anti-ganglioside and anti-ras p21 antibodies as markers of tumor progression.
Yamamura K, Mishima Y
The Journal of investigative dermatology 1990 Feb;94(2):174-82
The Journal of investigative dermatology 1990 Feb;94(2):174-82
Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes.
Holzmann B, Bröcker EB, Lehmann JM, Ruiter DJ, Sorg C, Riethmüller G, Johnson JP
International journal of cancer 1987 Apr 15;39(4):466-71
International journal of cancer 1987 Apr 15;39(4):466-71
Phenotypic dynamics of tumor progression in human malignant melanoma.
Bröcker EB, Suter L, Brüggen J, Ruiter DJ, Macher E, Sorg C
International journal of cancer 1985 Jul 15;36(1):29-35
International journal of cancer 1985 Jul 15;36(1):29-35
No comments: Submit comment
No validations: Submit validation data